A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia

ABSTRACT: Pentavalent antimonials (Sb5) are the first-line drugs for treating cutaneous leishmaniasis in Colombia; however, given problems with toxicity, compliance, availability, and cost, it is imperative to look for better therapeutic options. Intravenous amphotericin B (AmB) has been used extens...

Full description

Autores:

López Carvajal, Liliana
Vélez Bernal, Iván Darío
Asela Pinzón, Claudia Ximena
Cruz, Claudia
Alves, Fabiana
Robledo, Sara
Arana, Byron

Tipo de recurso:

Article of investigation

Fecha de publicación:

2018

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/21415

Acceso en línea:

http://hdl.handle.net/10495/21415

Palabra clave:

Anfotericina B
Amphotericin B
Leishmaniasis Cutánea
Leishmaniasis, Cutaneous
Leishmaniasis Cutánea - tratamiento farmacológico
Leishmaniasis, Cutaneous - drug therapy

Rights

openAccess

License

http://creativecommons.org/licenses/by/2.5/co/